Invest now
Vimta Labs share price
High risk
You have to be logged in to add this to Watchlist.- ₹653.90(1.81%)August 7, 2026 15:29:25 PM IST
- NSE
- BSE
- Vol : 171.36 K (NSE + BSE)Last 20 day avg : 813.95 K
Vimta Labs is trading 1.81% upper at Rs 653.90 as compared to its last closing price. Vimta Labs has been trading in the price range of 656.20 & 635.00. Vimta Labs has given 6.05% in this year & 6.03% in the last 5 days. Vimta Labs has TTM P/E ratio 32.90 as compared to the sector P/E of 41.77.There are 1 analysts who have initiated coverage on Vimta Labs. There are 0.00 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 21.04 Crores in its last quarter.Listed peers of Vimta Labs include Sun Pharmaceutical Industries (0.26%), Divi's Laboratories (-0.52%), Torrent Pharmaceuticals (-0.26%).The Mutual Fund holding in Vimta Labs was at 0.20% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Vimta Labs was at 4.41% in 30 Jun 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 08 Aug 2026, 01:00 AM IST
- BetaLow volatility0.73Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.31Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation2.11The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Vimta Labs News
Vimta Labs Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,949.00 | 0.26 | 4,67,619.37 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 8,248.50 | -0.52 | 2,18,971.76 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,952.00 | -0.26 | 1,88,351.43 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,472.00 | -0.20 | 1,18,914.83 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,115.20 | 0.81 | 1,11,241.63 | 21.19 | 4.24 | 0.09 | 14.22 |
Mutual Fund Ownership
View allVimta Labs Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-07-20 | Quarterly Results |
| 2026-05-06 | Audited Results & Final Dividend |
| 2026-01-28 | Quarterly Results |
| 2025-11-03 | Quarterly Results |
| 2025-07-17 | Quarterly Results |
About the company Vimta Labs
- IndustryBiotechnology & Drugs
- ISININE579C01029
- BSE Code524394
- NSE CodeVIMTALABS
Vimta Labs Limited is an India-based contract research and testing services provider. The Company operates through the Contract Research and Testing Services segment. It is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ore and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include drug discovery, development, and drug life cycle management support services; preclinical research and testing services for medical device companies; contract research and testing for agrochemical and specialty chemical companies; food testing and analytical development services to support manufacturers, processors, farmers, and retailers; contact research and development of biologics and peptides and electrical/electronic safety, environmental and physical security products testing.
Vimta Labs Share Price FAQs
Vimta Labs is trading at 653.90 as on Fri Aug 07 2026 09:59:25. This is 1.81% upper as compared to its previous closing price of 642.30.
The market capitalization of Vimta Labs is 2934.87 Cr as on Fri Aug 07 2026 09:59:25.
The average broker rating on Vimta Labs is Buy. The breakup of analyst rating is given below -
- 0.00 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Vimta Labs is 902.85 whereas the 52 wk low is 377.30
Vimta Labs can be analyzed on the following key metrics -
- TTM P/E: 32.90
- Sector P/E: 41.77
- Dividend Yield: 0.31%
- D/E ratio: -
Vimta Labs reported a net profit of 77.51 Cr in 2026.
The Mutual Fund Shareholding was 0.20% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Vimta Labs QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.